World Health Organization Treatment Recommendations for Nonsevere Fast-Breathing Pneumonia Need to Be Updated-Reply.

08:00 EDT 15th April 2019 | BioPortfolio

Summary of "World Health Organization Treatment Recommendations for Nonsevere Fast-Breathing Pneumonia Need to Be Updated-Reply."

No Summary Available


Journal Details

This article was published in the following journal.

Name: JAMA pediatrics
ISSN: 2168-6211


DeepDyve research library

PubMed Articles [35974 Associated PubMed Articles listed on BioPortfolio]

World Health Organization Treatment Recommendations for Nonsevere Fast-Breathing Pneumonia Need to Be Updated.

Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.

Pneumonia is the leading infectious killer of children. Rigorous evidence supporting antibiotic treatment of children with nonsevere fast-breathing pneumonia in low-resource African settings is lackin...

Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.

Globally, most deaths due to childhood pneumonia occur at the community level. Some countries are still using oral co-trimoxazole, despite a World Health Organization recommendation of oral amoxicilli...

Antibiotic Treatment of Nonsevere Pneumonia With Fast Breathing-Is the Pendulum Swinging?

Estimated impact of World Health Organization latent tuberculosis screening guidelines in a low TB incidence region: retrospective cohort study.

Latent tuberculosis (LTBI) screening and treatment is a key component of the World Health Organization (WHO) EndTB Strategy, but the impact of LTBI screening and treatment at a population level is unc...

Clinical Trials [8718 Associated Clinical Trials listed on BioPortfolio]

Effect of Chronic Arsenic Exposure on Malnutrition of Under Five Children

Early life malnutrition is associated with later life health problems, Particularly Stunting, which is a height-for-age Z score less than -2 standard deviation of World Health Organization...

World Health Organization Disability Assessment Schedule II (WHODAS-II) for Patients With Symptomatic Lumbar Spinal Stenosis

The main purpose of this study is to determine the measurement characteristics of WHODAS-II (World Health Organization Disability Assessment Schedule II), as well as to analyze its correla...

Sedation Versus No Sedation in a Spontaneous Breathing Trial

An important part of how we decide when a patient is ready to have their breathing tube removed is to have a person breathe without any machine breaths while the breathing tube is still in...

Clinical Signs and Symptoms of Anemia in Patients Over 75 Years

Anemia is a common pathology in geriatrics. According to the World Health Organization it affects 23.9% of subjects over 60 years in the world, and 8% of patients over 60 years in Europe. ...

3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi

The purpose of this study to assess the effectiveness of no antibiotic treatment for fast breathing, community-acquired childhood pneumonia in a malaria-endemic region of Malawi.

Medical and Biotech [MESH] Definitions

A specialized agency of the United Nations designed as a coordinating authority on international health work; its aim is to promote the attainment of the highest possible level of health by all peoples.

A state of physical, emotional, mental and social well-being in relation to SEXUALITY, according to the World Health Organization.

The World Health Organization's classification categories of health and health-related domains. The International Classification of Functioning, Disability and Health (ICF) consists of two lists: a list of body functions and structure, and a list of domains of activity and participation. The ICF also includes a list of environmental factors.

Drugs considered essential to meet the health needs of a population as well as to control drug costs. (World Health Organization Action Programme on Essential Drugs, 1994, p3)

A form of LEPROSY classified by the World Health Organization for the purpose of treatment, based on clinical manifestations and skin smear results. Patients with paucibacillary leprosy have fewer than six skin lesions with no causative agent MYCOBACTERIUM LEPRAE on any slit-skin smear testing. Paucibacillary leprosy encompasses indeterminate, borderline tuberculoid, and tuberculoid leprosy.

Quick Search


DeepDyve research library

Relevant Topic

Pneumonia (bronchopneumonia, lobar pneumonia and double pneumonia) is inflammation (swelling) of the tissue in one or both of your lungs. It is usually caused by an pneumococcal infection caused by bacteria called Streptococcus pneumoniae.  However,...

Searches Linking to this Article